For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Asterias Biotherapeutics, Inc.

USPTO Granted Patents = 22

CIPO Patents = 8

EPO Patents = 14

Forward Citations = 32

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Ramkumar Mandalam (7 out of 14 patents)

Melissa K Carpenter (7 out of 32 patents)

Jane S Lebkowski (5 out of 20 patents)

4. Joseph D Gold (5 out of 24 patents)

5. Yue Zhou (4 out of 27 patents)

6. Christopher Bankole Shogbon (4 out of 12 patents)

7. Ralph Brandenberger (4 out of 9 patents)

8. Nathan C Manley (3 out of 4 patents)

9. Yan Li (3 out of 30 patents)

10. Isabelle Nadeau-Demers (3 out of 3 patents)

11. Chunhui Xu (3 out of 17 patents)

12. Edward D Wirth, Iii (2 out of 2 patents)

13. R Scott Thies (2 out of 9 patents)

14. Erik Michael Whiteley (2 out of 3 patents)

15. Mohammad Hassanipour (1 out of 5 patents)

22 patents: Sort by Forward Citations

1. 12441983 - Suspension culture of human embryonic stem cells (2025-10-14),

2. 11920155 - Oligodendrocyte progenitor cell compositions (2024-03-05),

3. 11603518 - Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells (2023-03-14),

4. 11123374 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2021-09-21),

5. 10676714 - Suspension culture of human embryonic stem cells (2020-06-09),

6. 10351821 - Neural cell populations from primate pluripotent stem cells (2019-07-16),

7. 10344262 - Differentiation of primate pluripotent stem cells to hematopoietic lineage cells (2019-07-09),

8. 10286009 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2019-05-14),

9. 10221390 - Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells (2019-03-05),

10. 10059939 - Screening methods for human embryonic stem cells (2018-08-28),

11. 9803174 - Neural progenitor cell populations (2017-10-31),

12. 9790466 - Neural cell populations from primate pluripotent stem cells (2017-10-17),

13. 9745550 - Synthetic surfaces for culturing stem cell derived cardiomyocytes (2017-08-29),

14. 9587223 - Protocols for making hepatocytes from embryonic stem cells (2017-03-07),

15. 9243229 - Synthetic surfaces for culturing stem cell derived cardiomyocytes (2016-01-26),

Asterias Biotherapeutics, Inc. is a biotechnology company that focuses on the development and commercialization of novel therapeutics for the treatment of serious diseases. The company's main area of expertise is stem cell-based therapies. Asterias is dedicated to advancing innovative products to address unmet medical needs in areas such as neurology and oncology. Through its cutting-edge research and clinical trials, Asterias aims to provide patients and healthcare professionals with effective and safe treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#94 in Fremont, CA

#3,456 in California

#14,534 in US

#27,908 in the World

Fremont, CA, United States of America

Asterias Biotherapeutics, Inc.

Forward Citations = 32

32 inventors:

Ramkumar Mandalam (7 out of 14 patents)

Melissa K Carpenter (7 out of 32 patents)

Jane S Lebkowski (5 out of 20 patents)

4. Joseph D Gold (5 out of 24 patents)

5. Yue Zhou (4 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…